<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="yw3Y0KQRCd"&gt;&lt;a href="https://brakkeconsulting.com/pt/23877/"&gt;Not&#xED;cias e notas sobre sa&#xFA;de animal de 4 de outubro de 2013&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/23877/embed/#?secret=yw3Y0KQRCd" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for October 4, 2013&#x201D; &#x2014; Brakke Consulting Website" data-secret="yw3Y0KQRCd" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for October 4, 2013 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news transaction assistance &nbsp; earnings news Bioniche &nbsp; other news Alltech Animal Health International Elanco Fleming Labs Henry Schein Ishii Merck Neogen Pegasus Laboratories Sogeval Vetalis Laboratories Virbac Zoetis (Vetalis) Zoetis (arsenic) Zoetis (Ishii) &nbsp; ************************************ BRAKKE CONSULTING, INC. TRANSACTION ASSISTANCE When the Time Is Right Buying, selling or merging? We can help! Brakke Consulting assists many clients with mergers, acquisitions and divestitures. Our transaction experts can provide the insight, ability and contacts you need in the animal health, pet, and veterinary markets. Please contact any of our offices for a confidential consultation. &nbsp; www.BrakkeConsulting.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &nbsp; &gt; Bioniche Life Sciences Inc. announced financial results for its fiscal year ended June 30, 2013. Animal Health revenues in Fiscal 2013 were $31.5 million, as compared to $29.8 million in Fiscal 2012.&nbsp; Animal Health net income was $3.3 million as compared to a net loss of ($894,000) in Fiscal 2012. (Online.wsj.com) &nbsp; ************************************ COMPANY NEWS RELEASES &nbsp; &gt; Vetalis Laboratories announced an agreement with Zoetis for the distribution of its food animal nutraceutical products in several countries in Europe, Africa and the Middle East. (Animal Pharm)View Full Post;</description></oembed>
